|
6 Companies |
|
10 Products |
|
10 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
280 News |
|
| «123456» |
- ||| Trial completion, Enrollment change, Trial primary completion date: Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=120, Completed, Sponsor: University of Washington
Recruiting --> Completed | N=100 --> 120 | Trial primary completion date: Sep 2014 --> Apr 2014
- Trial completion, Enrollment change, Trial primary completion date: Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia (clinicaltrials.gov) - Oct 15, 2014
P=N/A, N=100, Completed, Sponsor: Mike O'Callaghan Federal Hospital
Recruiting --> Completed | N=100 --> 120 | Trial primary completion date: Sep 2014 --> Apr 2014 Recruiting --> Completed | N=12000 --> 100 | Trial primary completion date: Aug 2015 --> Oct 2014
- Trial initiation date, Trial primary completion date: Free DNA and Nucleosome Concentrations in Pathological Pregnancies (clinicaltrials.gov) - Oct 10, 2014
P=N/A, N=180, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
Recruiting --> Completed | N=12000 --> 100 | Trial primary completion date: Aug 2015 --> Oct 2014 Initiation date: Nov 2014 --> Jul 2015 | Trial primary completion date: May 2018 --> Jan 2019
- Enrollment change, Trial withdrawal: DHA-2: Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health (clinicaltrials.gov) - Sep 19, 2014
P=N/A, N=0, Withdrawn, Sponsor: Children's Hospital Medical Center, Cincinnati
Initiation date: Nov 2014 --> Jul 2015 | Trial primary completion date: May 2018 --> Jan 2019 N=90 --> 0 | Not yet recruiting --> Withdrawn
- nifedipine immediate release / Generic mfg., labetalol / Generic mfg.
Trial initiation date, Trial primary completion date: Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy (clinicaltrials.gov) - Sep 15, 2014
P4, N=671, Not yet recruiting, Sponsor: Gynuity Health Projects
N=90 --> 0 | Not yet recruiting --> Withdrawn Initiation date: Aug 2013 --> Nov 2014 | Trial primary completion date: Dec 2014 --> Dec 2015
- Head-to-Head, Adherence: MICA: Cornell University-Micronutrient Initiative Calcium Supplementation Study (clinicaltrials.gov) - Sep 12, 2014
P=N/A, N=900, Not yet recruiting, Sponsor: Cornell University
- | carbetocin / Generic mfg.
Trial completion, Enrollment change: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - Sep 8, 2014
P3, N=120, Completed, Sponsor: khalid abd aziz mohamed
Initiation date: Aug 2013 --> Nov 2014 | Trial primary completion date: Dec 2014 --> Dec 2015 Recruiting --> Completed | N=60 --> 120
- Trial initiation date: DHA-2: Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health (clinicaltrials.gov) - Aug 29, 2014
P=N/A, N=90, Not yet recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting --> Completed | N=60 --> 120 Initiation date: Jul 2014 --> Dec 2014
- Biomarker, Trial completion, Trial primary completion date: Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications (clinicaltrials.gov) - Aug 28, 2014
P=N/A, N=280, Completed, Sponsor: Assistance Publique Hopitaux De Marseille
Initiation date: Jul 2014 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: May 2010 --> Jul 2012
- Clinical: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=3640, Not yet recruiting, Sponsor: Queen Mary University of London
- Clinical: Restrictive Fluid Therapy in Severe Preeclampsia (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=42, Recruiting, Sponsor: University of Sao Paulo General Hospital
- New P1 trial: Phase I Study of Nicotinamide for Early Onset Preeclampsia (clinicaltrials.gov) - Aug 11, 2014
P1, N=10, Recruiting, Sponsor: University of North Carolina, Chapel Hill
- Trial initiation date: A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen (clinicaltrials.gov) - Aug 1, 2014
P4, N=200, Not yet recruiting, Sponsor: Gynuity Health Projects
Recruiting --> Completed | Trial primary completion date: May 2010 --> Jul 2012 Initiation date: Jun 2014 --> Oct 2014
- Reasanz (serelaxin) / Novartis
Enrollment change, Trial termination, Trial primary completion date: Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia (clinicaltrials.gov) - Jul 15, 2014
P2, N=3, Terminated, Sponsor: Novartis Pharmaceuticals
Initiation date: Jun 2014 --> Oct 2014 N=60 --> 3 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Aug 2014; Novartis terminated this study due to internal, strategic decisions.
- aspirin / Generic mfg.
Enrollment closed, Trial primary completion date: Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia (clinicaltrials.gov) - Jul 15, 2014
P4, N=104, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Qu
N=60 --> 3 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Aug 2014; Novartis terminated this study due to internal, strategic decisions. Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014
- Trial primary completion date: ANGIODYS: Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=24, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014 Trial primary completion date: Jun 2014 --> Sep 2015
- || aspirin / Generic mfg.
New P3 trial: PROVAS: Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. (clinicaltrials.gov) - Jun 26, 2014
P3, N=372, Not yet recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
- Clinical: Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach (clinicaltrials.gov) - Jun 17, 2014
P=N/A, N=100, Recruiting, Sponsor: University of Washington
- aspirin / Generic mfg.
Enrollment closed: EPAPP: Early Prevention of Preeclampsia Study (clinicaltrials.gov) - Jun 12, 2014
P=N/A, N=684, Active, not recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Jun 2014 --> Sep 2015 Recruiting --> Active, not recruiting
- |||||| ATryn (antithrombin) / LFB SA, Knight Therap
Enrollment open: PRESERVE-1: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (clinicaltrials.gov) - Jun 1, 2014
P3, N=120, Recruiting, Sponsor: rEVO Biologics
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Clinical: DHA-2: Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health (clinicaltrials.gov) - May 11, 2014
P=N/A, N=90, Not yet recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
- carbetocin / Generic mfg.
Trial primary completion date: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - May 10, 2014
P0, N=60, Recruiting, Sponsor: khalid abd aziz mohamed
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2014 --> Jun 2014
- carbetocin / Generic mfg.
Trial completion date: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - May 10, 2014
P0, N=60, Recruiting, Sponsor: khalid abd aziz mohamed
Trial primary completion date: Sep 2014 --> Jun 2014 Trial completion date: Oct 2014 --> Jun 2014
- || Trial initiation date: Assessing Childbirth-related Complications at the Community Level in Kenya (clinicaltrials.gov) - Apr 24, 2014
P=N/A, N=585, Completed, Sponsor: Wilson Liambila
Trial completion date: Oct 2014 --> Jun 2014 Initiation date: Oct 2012 --> Aug 2012
- ||| Trial completion: Assessing Childbirth-related Complications at the Community Level in Kenya (clinicaltrials.gov) - Apr 24, 2014
P=N/A, N=585, Completed, Sponsor: Wilson Liambila
Initiation date: Oct 2012 --> Aug 2012 Not yet recruiting --> Completed
- Trial suspension: Gene Expression In Pregnancies Complicated by Preeclampsia (clinicaltrials.gov) - Apr 20, 2014
P=N/A, N=125, Suspended, Sponsor: University of Rochester
Not yet recruiting --> Completed Recruiting --> Suspended
- Enrollment change: Gene Expression In Pregnancies Complicated by Preeclampsia (clinicaltrials.gov) - Apr 20, 2014
P=N/A, N=125, Suspended, Sponsor: University of Rochester
Recruiting --> Suspended N=50 --> 125
- carbetocin / Generic mfg.
Enrollment open: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - Apr 10, 2014
P0, N=60, Recruiting, Sponsor: khalid abd aziz mohamed
N=50 --> 125 Active, not recruiting --> Recruiting
- | Trial completion: New Magnesium Sulphate Protocol for Pre-eclampsia (clinicaltrials.gov) - Apr 6, 2014
P3, N=240, Completed, Sponsor: Cairo University
Active, not recruiting --> Recruiting Recruiting --> Completed
- | New P4 trial: A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen (clinicaltrials.gov) - Mar 17, 2014
P4, N=200, Not yet recruiting, Sponsor: Gynuity Health Projects
- Enrollment change: HUPP: Hypertension and Urine Protease Activity in Preeclampsia (clinicaltrials.gov) - Mar 13, 2014
P=N/A, N=30, Recruiting, Sponsor: Odense University Hospital
Recruiting --> Completed N=40 --> 30
- | NN1213 / Novo Nordisk
Trial completion: RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil (clinicaltrials.gov) - Feb 22, 2014
P3, N=734, Completed, Sponsor: NICHD Global Network for Women's and Children's Health
N=40 --> 30 Recruiting --> Completed
- |||||||||| ATryn (antithrombin) / LFB SA, Knight Therap
New P3 trial: PRESERVE-1: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (clinicaltrials.gov) - Feb 9, 2014
P3, N=120, Not yet recruiting, Sponsor: rEVO Biologics
- nifedipine immediate release / Generic mfg., labetalol / Generic mfg.
Enrollment open: Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy (clinicaltrials.gov) - Jan 30, 2014
P4, N=671, Recruiting, Sponsor: Gynuity Health Projects
Recruiting --> Completed Not yet recruiting --> Recruiting
- labetalol / Generic mfg.
Trial initiation date: LAMPET: Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial (clinicaltrials.gov) - Jan 28, 2014
P2/3, N=8000, Suspended, Sponsor: Baylor College of Medicine
Not yet recruiting --> Recruiting Initiation date: May 2003 --> Jun 2015
- || hydralazine hydrochloride / Generic mfg., labetalol / Generic mfg.
New P2/3 trial: Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. (clinicaltrials.gov) - Jan 28, 2014
P2/3, N=180, Recruiting, Sponsor: Dow University of Health Sciences
- | hydralazine hydrochloride / Generic mfg., labetalol / Generic mfg.
Enrollment open: Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. (clinicaltrials.gov) - Jan 28, 2014
P2/3, N=180, Recruiting, Sponsor: Dow University of Health Sciences
Initiation date: May 2003 --> Jun 2015 Not yet recruiting --> Recruiting
- Bridion (sugammadex) / Merck (MSD)
Trial completion: Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients (clinicaltrials.gov) - Jan 9, 2014
P4, N=80, Completed, Sponsor: Kocaeli University
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open: Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia (clinicaltrials.gov) - Dec 29, 2013
P=N/A, N=12000, Recruiting, Sponsor: Mike O'Callaghan Federal Hospital
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE) (clinicaltrials.gov) - Dec 17, 2013
P=N/A, N=14990, Recruiting, Sponsor: Duke University
Not yet recruiting --> Recruiting N=36600 --> 14990
- Enrollment open: A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka (clinicaltrials.gov) - Dec 15, 2013
P=N/A, N=7883, Enrolling by invitation, Sponsor: Harvard School of Public Health
N=36600 --> 14990 Not yet recruiting --> Enrolling by invitation
- Enrollment closed: Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=66, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Not yet recruiting --> Enrolling by invitation Recruiting --> Active, not recruiting
- Trial completion: ICASH: Impedance Cardiographic (ICG) Assessment of Pregnant Women With Severe Hypertension to Assess Impact of Standard Therapy (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=30, Completed, Sponsor: University of Mississippi Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment change: Screen-tox: Prediction and Prevention of Preeclampsia by First Trimester Ultrasound (clinicaltrials.gov) - Nov 28, 2013
P=N/A, N=602, Completed, Sponsor: Norwegian University of Science and Technology
Recruiting --> Completed N=1500 --> 602
- Trial completion: Screen-tox: Prediction and Prevention of Preeclampsia by First Trimester Ultrasound (clinicaltrials.gov) - Nov 28, 2013
P=N/A, N=602, Completed, Sponsor: Norwegian University of Science and Technology
N=1500 --> 602 Active, not recruiting --> Completed
- || New P2/3 trial: Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia (clinicaltrials.gov) - Nov 18, 2013
P2/3, N=124, Recruiting, Sponsor: Complejo Hospitalario Dr. Arnulfo Arias Madrid
- | Bridion (sugammadex) / Merck (MSD)
New P4 trial: Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients (clinicaltrials.gov) - Oct 28, 2013
P4, N=80, Completed, Sponsor: Kocaeli University
- Trial completion: ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury (clinicaltrials.gov) - Oct 16, 2013
P=N/A, N=370, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Recruiting --> Completed
- aspirin / Generic mfg.
Enrollment change: EPAPP: Early Prevention of Preeclampsia Study (clinicaltrials.gov) - Oct 13, 2013
P=N/A, N=684, Recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed N=220 --> 684
- Enrollment open: HUPP: Hypertension and Urine Protease Activity in Preeclampsia (clinicaltrials.gov) - Aug 18, 2013
P=N/A, N=30, Recruiting, Sponsor: Odense University Hospital
N=220 --> 684 Not yet recruiting --> Recruiting